Altimmune, Inc. (ALT)
2.99
+0.06
(+2.05%)
USD |
NASDAQ |
May 27, 15:51
Altimmune Free Cash Flow : -71.67M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| Amgen, Inc. | 8.597B |
| Verastem, Inc. | -160.57M |
| Karyopharm Therapeutics, Inc. | -59.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.94M |
| Cash from Investing (Quarterly) | -3.69M |
| Cash from Financing (Quarterly) | 78.47M |
| Free Cash Flow Per Share (Quarterly) | -0.1684 |
| Free Cash Flow to Equity (Quarterly) | -21.12M |
| Free Cash Flow to Firm (Quarterly) | -19.90M |
| Free Cash Flow Yield | -24.21% |